DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
André F, OʼRegan R, Ozguroglu M et al.
Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial.
Lancet Oncol 2014;
15: 580-591
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.